Skip to content
2000
image of Box-bhenken Design Combined with 3D Surface Methodology for Optimization of an Eco-friendly HPLC Method to Determine Venetoclax in Human Plasma, and its Bioanalytical Method Validation According to ICH M10 Guideline

Abstract

Aims

Venetoclax is a selective inhibitor of the prosurvival protein BCL-2 approved by the Food Drug Administration in 2016, restoring the apoptic ability of malignant cells. In this study, a fast, highly accurate and precise HPLC method was developed for the analysis of Venetoclax in human plasma.

Methods

The optimization of the method was investigated according to Box-Bhenken Design combined with 3D surface methodology. The chromatographic separation was performed in gradient mode with an Ascentis Express C column (2.7 μm, 4.6 mm × 10 cm). Agomelatine was used as an internal standard to increase accuracy. The method was completely validated according to ICH guideline M10 bioanalytical method validation. Additionally, the greenness of the method was scaled with NEMI, Analytical Ecoscale, AGREE, and GAPI greenness metrics.

Results

The method was linear in the range of 1.67-12.50 µg/mL with a calculated R2 of 0.99; LOD and LOQ were 0.34 µg/mL and 1.02 µg/mL, respectively. The recovery was in the range of 102.6% to 99.08%, and with an RSD% of less than 1.00%. The analytical eco scale and AGREE score of the current method were 85 and 0.55, respectively.

Conclusion

The approach that was developed herein exhibits green, rapidity, high levels of accuracy and precision, cost-effectiveness, and ease of use in the context of clinical and pharmacokinetic investigations.

Loading

Article metrics loading...

/content/journals/cac/10.2174/0115734110352089241114112537
2024-11-21
2025-01-19
Loading full text...

Full text loading...

References

  1. Besbes S. Mirshahi M. Pocard M. Billard C. New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget 2015 6 15 12862 12871 10.18632/oncotarget.3868 25970783
    [Google Scholar]
  2. Carneiro B.A. El-Deiry W.S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 2020 17 7 395 417 10.1038/s41571‑020‑0341‑y 32203277
    [Google Scholar]
  3. Deeks E.D. Venetoclax: First Global Approval. Drugs 2016 76 9 979 987 10.1007/s40265‑016‑0596‑x 27260335
    [Google Scholar]
  4. Pillai O. Dhanikula A.B. Panchagnula R. Drug delivery: an odyssey of 100 years. Curr. Opin. Chem. Biol. 2001 5 4 439 446 10.1016/S1367‑5931(00)00226‑X 11470608
    [Google Scholar]
  5. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208573Orig1s000ClinPharmR.pdf 2023
  6. Lee R. Statistical Design of Experiments for Screening and Optimization. Chemieingenieurtechnik (Weinh.) 2019 91 3 191 200 10.1002/cite.201800100
    [Google Scholar]
  7. Ferreira S.L.C. Bruns R.E. Ferreira H.S. Matos G.D. David J.M. Brandão G.C. da Silva E.G.P. Portugal L.A. dos Reis P.S. Souza A.S. dos Santos W.N.L. Box-Behnken design: An alternative for the optimization of analytical methods. Anal. Chim. Acta 2007 597 2 179 186 10.1016/j.aca.2007.07.011 17683728
    [Google Scholar]
  8. Pokar D. Sahu A.K. Sengupta P. LC-Q-TOF-MS driven identification of potential degradation impurities of venetoclax, mechanistic explanation on degradation pathway and establishment of a quantitative analytical assay method. J. Anal. Sci. Technol. 2020 11 1 54 10.1186/s40543‑020‑00252‑4
    [Google Scholar]
  9. Žigart N. Časar Z. Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD Principles. ACS Omega 2020 5 28 17726 17742 10.1021/acsomega.0c02338 32715260
    [Google Scholar]
  10. Yasu T. Gando Y. Nomura Y. Kosugi N. Kobayashi M. Determination of Venetoclax Concentration in Plasma Using High-Performance Liquid Chromatography. J. Chromatogr. Sci. 2023 61 5 480 483 10.1093/chromsci/bmac027 35383356
    [Google Scholar]
  11. Fukuda N. Kobayashi T. Sato H. Akamine Y. Takahashi N. Miura M. Quantitation of Venetoclax in Human Plasma by High-Performance Liquid Chromatography with Ultraviolet Detection. J. Chromatogr. Sci. 2023 62 1 58 64 10.1093/chromsci/bmac080 36316274
    [Google Scholar]
  12. Koehl N.J. Henze L.J. Holm R. Kuentz M. Keating J.J. De Vijlder T. Marx A. Griffin B.T. Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax. J. Pharm. Sci. 2022 111 1 164 174 10.1016/j.xphs.2021.09.008 34516990
    [Google Scholar]
  13. Inturi S. Yejerla R.K. Jujjuru N.S. Avula P.R. Evaluation of Deuterium-Labeled Internal Standard for the Measurement of Venetoclax by HPLC-ESI -Tandem Mass Spectrometry. J. Young Pharm. 2018 10 4 392 398 10.5530/jyp.2018.10.87
    [Google Scholar]
  14. Eisenmann E.D. Jin Y. Weber R.H. Sparreboom A. Baker S.D. Development and validation of a sensitive UHPLC-MS/MS analytical method for venetoclax in mouse plasma, and its application to pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2020 1152 122176 10.1016/j.jchromb.2020.122176 32534260
    [Google Scholar]
  15. 1994 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/reviewer-guidance-validation-chromatographic-methods
  16. Guideline I.H. Bioanalytical method validation and study sample analysis M10. Geneva, Switzerland 2022
    [Google Scholar]
  17. Derringer G. Suich R. Simultaneous Optimization of Several Response Variables. J. Qual. Technol. 1980 12 4 214 219 10.1080/00224065.1980.11980968
    [Google Scholar]
  18. Vera Candioti L. De Zan M.M. Cámara M.S. Goicoechea H.C. Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta 2014 124 123 138 10.1016/j.talanta.2014.01.034 24767454
    [Google Scholar]
  19. Gniazdowska E. Gilant E. Bus-Kwasnik K. Review Article ICH M10 GUIDELINE- A HARMONIZED GLOBAL APPROACH TO BIOANALYSIS. Prospects in Pharmaceutical Sciences 2023 21 3 57 63 10.56782/pps.152
    [Google Scholar]
  20. Cavazzuti M. Design of experiments. Optimization methods: From theory to design scientific and technological aspects in mechanics Springer 2013 13 42
    [Google Scholar]
  21. Guideline I.H. Bioanalytical method validation M10. 2019
    [Google Scholar]
  22. Majors R. Raynie D. The greening of the chromatography laboratory LCGC North America 2011 29 2 118 134
    [Google Scholar]
  23. Keith L.H. Gron L.U. Young J.L. Green analytical methodologies. Chem. Rev. 2007 107 6 2695 2708 10.1021/cr068359e 17521200
    [Google Scholar]
  24. Sajid M. Płotka-Wasylka J. Green analytical chemistry metrics: A review. Talanta 2022 238 Pt 2 123046 10.1016/j.talanta.2021.123046 34801903
    [Google Scholar]
  25. Tobiszewski M. Marć M. Gałuszka A. Namieśnik J. Green Chemistry Metrics with Special Reference to Green Analytical Chemistry. Molecules 2015 20 6 10928 10946 10.3390/molecules200610928 26076112
    [Google Scholar]
  26. Pena-Pereira F. Wojnowski W. Tobiszewski M. AGREE—Analytical GREEnness Metric Approach and Software. Anal. Chem. 2020 92 14 10076 10082 10.1021/acs.analchem.0c01887 32538619
    [Google Scholar]
  27. Izutsu K. Yamamoto K. Kato K. Ishikawa T. Fukuhara N. Terui Y. Choi I. Humphrey K. Kim S.Y. Okubo S. Ogawa N. Nishimura Y. Salem A.H. Maruyama D. Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma. Int. J. Hematol. 2021 113 3 370 380 10.1007/s12185‑020‑03024‑3 33094474
    [Google Scholar]
  28. Salem A.H. Agarwal S.K. Dunbar M. Nuthalapati S. Chien D. Freise K.J. Wong S.L. Effect of Low‐ and High‐Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First‐in‐Class BCL‐2 Inhibitor. J. Clin. Pharmacol. 2016 56 11 1355 1361 10.1002/jcph.741 27029823
    [Google Scholar]
/content/journals/cac/10.2174/0115734110352089241114112537
Loading
/content/journals/cac/10.2174/0115734110352089241114112537
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: HPLC ; green chemistry ; Box-behnken design ; ICH M10 ; venetoclax
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test